ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Construction and validation of a progression prediction model for locally advanced rectal cancer patients received neoadjuvant chemoradiotherapy followed by total mesorectal excision based on machine learning

Hu, Jitao; Sheng, Yuanyuan; Ma, Jinlong; Tang, Yujie; Liu, Dong; Zhang, Jianqing; Wei, Xudong; Yang, Yang; Liu, Yueping*; Zhang, Yongqiang*; Wang, Guiying*河北医科大学
Frontiers in Oncology2024-1-24DOI: 10.3389/fonc.2023.1231508
6阅读
引用收藏
分享

摘要

Background We attempted to develop a progression prediction model for local advanced rectal cancer(LARC) patients who received preoperative neoadjuvant chemoradiotherapy(NCRT) and operative treatment to identify high-risk patients in advance.Methods Data from 272 LARC patients who received NCRT and total mesorectal excision(TME) from 2011 to 2018 at the Fourth Hospital of Hebei Medical University were collected. Data from 161 patients with rectal cancer (each sample with one target variable (progression) and 145 characteristic variables) were included. One Hot Encoding was applied to numerically represent some characteristics. The K-Nearest Neighbor (KNN) filling method was used to determine the missing values, and SmoteTomek comprehensive sampling was used to solve the data imbalance. Eventually, data from 135 patients with 45 characteristic clinical variables were obtained. Random forest, decision tree, support vector machine (SVM), and XGBoost were used to predict whether patients with rectal cancer will exhibit progression. LASSO regression was used to further filter the variables and narrow down the list of variables using a Venn diagram. Eventually, the prediction model was constructed by multivariate logistic regression, and the performance of the model was confirmed in the validation set.Results Eventually, data from 135 patients including 45 clinical characteristic variables were included in the study. Data were randomly divided in an 8:2 ratio into a data set and a validation set, respectively. Area Under Curve (AUC) values of 0.72 for the decision tree, 0.97 for the random forest, 0.89 for SVM, and 0.94 for XGBoost were obtained from the data set. Similar results were obtained from the validation set. Twenty-three variables were obtained from LASSO regression, and eight variables were obtained by considering the intersection of the variables obtained using the previous four machine learning methods. Furthermore, a multivariate logistic regression model was constructed using the data set; the ROC indicated its good performance. The ROC curve also verified the good predictive performance in the validation set.Conclusions We constructed a logistic regression model with good predictive performance, which allowed us to accurately predict whether patients who received NCRT and TME will exhibit disease progression.

学科与关键词

关键词
deep learningartificial intelligencetotal mesorectal excisionneoadjuvant chemoradiotherapylocal advanced rectal cancer
相关
加载中…
  • Predicting pathologic complete response in locally advanced rectal cancer patients after neoadjuvant therapy: a machine learning model using XGBoost
    Chen, Xijie; Wang, Wenhui; Chen, Junguo; Xu, Liang; He, Xiaosheng; Lan, Ping; Hu, Jiancong*; Lian, Lei*INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022, 37(7): 1621-1634.被引 3
  • External validation and comparison of MR-based radiomics models for predicting pathological complete response in locally advanced rectal cancer: a two-centre, multi-vendor study
    Wei, Qiurong; Chen, Zeli; Tang, Yehuan; Chen, Weicui; Zhong, Liming; Mao, Liting; Hu, Shaowei; Wu, Yuankui; Deng, Kan; Yang, Wei*; Liu, Xian*European Radiology, 2023, 33(3): 1906-1917.被引 3
  • Development of a machine learning algorithm to predict complications of total laparoscopic anterior resection and natural orifice specimen extraction surgery in rectal cancer
    Wei, Ran; Guan, Xu; Liu, Enrui; Zhang, Weiyuan; Lv, Jingfang; Huang, Haiyang; Zhao, Zhixun; Chen, Haipeng; Liu, Zheng; Jiang, Zheng*; Wang, Xishan*EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2023, 49(7): 1258-1268.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2024-01-24
卷期
第 13 卷
页码
1231508
DOI
10.3389/fonc.2023.1231508
成果收录
SCIE
资助标注
Hebei Natural Science Foundation [H2020206485, H2022206355]

作者

  • H

    Hu, Jitao (第一作者)

    hebei med univ

  • S

    Sheng, Yuanyuan

    hebei univ sci & technol

查看全部 11 位作者收起作者
  • M

    Ma, Jinlong

    hebei univ sci & technol

  • T

    Tang, Yujie

    hebei med univ

  • L

    Liu, Dong

    hebei med univ

  • Z

    Zhang, Jianqing

    hebei med univ

  • W

    Wei, Xudong

    hebei med univ

  • Y

    Yang, Yang

    hebei med univ

  • L

    Liu, Yueping (通讯)

    hebei med univ

  • Z

    Zhang, Yongqiang (通讯)

    hebei univ sci & technol

  • W

    Wang, Guiying (通讯)

    hebei med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417